Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1129191

registered interest
date	03/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many prescriptions of (a) individual benzodiazepine drugs and (b) individual antidepressants were dispensed in the community in 2018.
tabling member constituency	Bristol North West
tabling member printed	Darren Jones
uin	259400
answer	answer is ministerial correction date of answer 11/06/2019 answer text <p>Information on the number of prescription items from the Prescription Cost Analysis system for benzodiazepines and antidepressants written in the United Kingdom and dispensed in the community in England, for the year 2018 can be found in the attached tables.</p><p>The data available is at prescription item level by presentation. Prescriptions are prescribed either by a paper prescription form or via an Electronic Prescription Service message. Each single item written on the form is counted as a prescription item. No information is available for those prescriptions written but not dispensed.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 11/06/2019 16:51:00 question first ministerially corrected 12/06/2019 14:34:05 answering member 4455 label Biography information for Seema Kennedy attachment 1 file name PQ259400 table formatted.docx title Prescription data benzodiazipines & antidepressant previous answer version 122124 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	4621 label Biography information for Darren Jones

1127908

registered interest
date	21/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Mental Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether an assessment has been made of the potential benefits of including a mental health professional with knowledge of diabetes in every diabetes care team.
tabling member constituency	Ealing Central and Acton
tabling member printed	Dr Rupa Huq
uin	257109
answer	answer is ministerial correction date of answer 29/05/2019 answer text <p>It is for individual clinical commissioning groups to commission treatment and services for people with diabetes and they are best placed to identify what is needed in their local areas.</p><p>On 21 March 2018, NHS England and NHS Improvement along with the National Collaborating Cenre for Mental Health published ‘The Improving Access to Psychological Therapies (IAPT) Pathway for People with Long-term Physical Health Conditions and Medically Unexplained Symptoms’.</p><p>IAPT services provide evidence based treatments for people with anxiety and depression and the services are co-located in existing primary and secondary care physical health pathways. IAPT services will target the needs of people with depression and anxiety disorders who also have long-term conditions such as diabetes.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 29/05/2019 13:39:35 answering member 4455 label Biography information for Seema Kennedy
tabling member	4511 label Biography information for Dr Rupa Huq

1126321

registered interest
date	13/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gender Dysphoria: Children
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they intend to publish the results of the research project started in 2011 by the NHS Gender Identity Development Service Early pubertal suppression in a carefully selected group of adolescents with gender identity disorder; and if not, whether they will arrange for the data gathered by that study to be made available to other researchers.
tabling member printed	Lord Lucas
uin	HL15681
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The research is an ethically approved study being carried out by the Tavistock and Portman NHS Foundation Trust since 2011, which is the largest provider of services for the alleviation of gender dysphoria in the United Kingdom.</p><p>The study will evaluate early pubertal suppression in a carefully selected group of adolescents with a clinical diagnosis of gender dysphoria. There are 44 young people taking part in the study.</p><p>The Tavistock and Portman NHS Foundation Trust has plans to publish the data <ins class="ministerial">on the blocker and cross-sex hormones, for those who were appropriate for this, as</ins><del class="ministerial">once</del> all of the young people in the study have reached <ins class="ministerial">this</ins><del class="ministerial">the</del> stage<ins class="ministerial">.</ins> <del class="ministerial">when a clinical decision is made about moving from pubertal suppressants to cross-sex hormones, which the Trust expects to occur in the next 12 months.</del></p> answering member printed Baroness Blackwood of North Oxford question first answered 22/05/2019 14:51:30 question first ministerially corrected 31/07/2019 15:30:59 answering member 4019 label Biography information for Baroness Blackwood of North Oxford previous answer version 119577 answering member printed Baroness Blackwood of North Oxford answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1879 label Biography information for Lord Lucas